Read Our Complete Guide to Next-Generation ADCs To Discover

  • Holistic ADC Design: Learn how each component, antibody, linker and payload shapes overall efficacy
  • Payload Optimization: Strategies to enhance potency, safety and selectivity through a payload-focused approach
  • Antigen & Linker Selection: Complementary antigen/payload pairs & linker chemistry roles in therapeutic precision
  • DMPK & Pharmacology Insight: DMPK profile optimization & integrated translational design for clinical performance
  • Future Outlook: Where is the field heading and how do we get there?

Conventionally seen as the domain of large-molecule specialists, delivering next generation ADCs will also rely on small-molecule focused optimization of payloads, linkers and conjugation strategies, demanding a truly integrated, cross-disciplinary approach.

Discover how smarter linkers and a payload-focused strategy is reshaping the future of ADCs, and how you can stay ahead of the curve

 

To learn more about Sygnature Discovery's Expertise in Antibody Drug Conjugates, please [click here]